Notable News to Watch: Realm Therapeutics plc (NASDAQ: RLM)

Realm Therapeutics plc (NASDAQ: RLM) stock accomplished trade value at $3.85 with -0.52% and traded volume 15836 shares in recent trading period versus to an average volume of 28.01K. The stock demonstrated move of -5.41% in previous 5 days graph. Its quarterly performance stands with the percentage of 123.36% while its year to date performance showed change of 108.11%. 

Realm Therapeutics plc (NASDAQ: RLM) declared the completion of its previously declared Assets Disposal representing certain assets, which comprise the Vashe® wound care royalty stream, an FDA 510(k)-cleared anti-itch hydrogel, which was formerly marketed as Aurstat™, HOCI related equipment, intellectual property (including know-how, patents and copyrights), program records, and certain assigned contracts and intellectual property licenses (as detailed in the Circular to Shareholders issued on February 15, 2019). Gross proceeds of the Assets Disposal are $10 million.

Realm continues to assess options available to maximize shareholder value through the strategic review. The Company remains in discussions with interested parties regarding a potential strategic transaction and intends to update the market with respect thereto in early Q2 2019. The net proceeds of the Assets Disposal will augment the Company’s current cash resources, which may be deployed in event of such a transaction.

Leave a Reply

Your email address will not be published. Required fields are marked *